secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001773751-22-000226
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q3 revenue $144.8M (+95% YoY); raises FY 2022 guidance; expects Q4 Adj. EBITDA profitability
--------------------------------------------------------------------------------

- Revenue of $144.8M, up 95% YoY; net loss $(18.8)M vs $(15.9)M a year ago.
- Adjusted EBITDA improved to $(6.1)M from $(9.8)M; expects Q4 2022 Adjusted EBITDA profitability.
- Subscriptions reached 991,000 (+80% YoY); Q3 net new subscriptions all-time high >170,000.
- Raises FY 2022 revenue guidance to $519-522M; Adjusted EBITDA guidance to $(20)-$(18)M.
- Gross margin expanded to 79% from 74% YoY; net loss improved on adjusted basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/0001773751-22-000226-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375122000226/hims-20221107.htm
  HTML page:      https://secwatch.observer/filing/0001773751-22-000226

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer